Category Archives: FDA Stem Cell Trials

Mayo Clinic's ophthalmology department was one of the major participating centers in the recently announced federal study on macular degeneration treatments. Avastin and Lucentis, both made by Genentech were tested and found to be equally effective in halting eye damage that leads to blindness. Avastin, the "off label" drug, costs roughly 50 dollars per treatment Follow this link: Macular Degeneration Drugs - Video … Continue reading →

About the Video: Experts in Parkinson's Disease have revised the guidelines for diagnosing and treating the disease in order to help people receive the best care. In this two-part program with Dr Read this article: Parkinson's Disease Guidelines (Part 2) - Video … Continue reading →

August 22, 2007 presentation by Ron Levy for the Stanford School of Medicine Medcast lecture series. Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective See the rest here: Monoclonal Antibodies: Stanford Academia-Industry Collaboration - Video … Continue reading →

Ellen Feigal, MD, led a workshop at the 2011 CIRM Grantee Meeting on the Target Product Profile (TPP). The TPP is a methodology for summarizing a drug development program which can facilitate communication between the drug's sponsor and the Federal Drug Administration. Feigal is Senior Vice President, Research and Development at the California Institute for Regenerative Medicine (CIRM). Visit link: Target Product Profile: Ellen Feigal - 2011 CIRM Grantee Meeting - Video … Continue reading →

Full story: is.gd - Also known as Lou Gehrig's disease, ALS is a fatal neurodegenerative disease with no known cure. Drs. View post: ALS Stem Cell Trial at Emory - Video … Continue reading →

Treatment - II - Topics include FDA's approval of first stem-cell clinical trial, Geron's patient selection and approach, the promise of stem cells to heal the spinal cord. Link: Stephen McKenna MD - 8 - Video … Continue reading →

FDA approves patient trials for stem cell treatment of Lou G See original here: StemCellTV Daily Report-October 29, 2011 - Video … Continue reading →

FDA's release of the hold on Geron's Phase I embryonic stem cell trial in humans marks the most important milestone for regenerative medicine and leading scientists and physicians. Link: Dr. Alimorad Farshchian statement on embryonic stem cells - Video … Continue reading →

Will BCG be around for the Nathan/Foustman human trials to cure Type 1 (autoimmune) diabetes? http://www.npr.org Are you a 'noncompiant' patient, according to your doctor? http://www.alliesvoice.com (March 2009). More here: Love Diabetes: BCG and Noncompliant Patients - Video … Continue reading →

Click Here for Website MF3Shop.com Doctors, Celebrities, Athletes and sick people all agree unanimously that MFIII of Switzerland Live Cell Placenta therapy is the World's most bio-technologically developed and effective Natural Nutritional Supplement for health, beauty, Antiaging, endurance and stamina. Read more: MFIII Switzerland PE Sheep Placenta Glandular therapy Study - Client Interviews - Video … Continue reading →